HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY Surgical Robotic System, the first single-use endovascular robotic system, today announced a highly successful extended joint pre- clinical animal study held at a leading European-based research lab. A team of six leading…Read More
Microbot Medical Achieved 100 Success Rate for LIBERTY in Extensive PreClinical Animal Study Performed by Leading European Physicians
